elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
b303600429a32c0f3eee05ebcb76b02bc22464b2
b303600429a32c0f3eee05ebcb76b02bc22464b2
Reference
http://www.wikidata.org/reference/b303600429a32c0f3eee05ebcb76b02bc22464b2
Q28371465-29838CC0-76D6-471F-B16D-A0443E9DE390
wasDerivedFrom
b303600429a32c0f3eee05ebcb76b02bc22464b2
Reference
http://www.wikidata.org/reference/b303600429a32c0f3eee05ebcb76b02bc22464b2
type
Reference
P1640
CIViC database
P248
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P813
2020-04-30T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P854
1233
P813
0c5f07ea6b6e92dd89849b978518123d